Loading...
| A03131 | Pages: NA | Feb 2022 | 4804 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Glycosylated Peptide Market
Request Now !Glycosylated peptide are used as a mediators of key biological function with unique intrinsic properties with potential to treat variety of diseases. Glycosylation of peptide drugs benefits with key features such as increased half-life, provides extended dosing duration, better solubility, and improved response to the therapy. The key factors that drive the market growth are the benefits of these peptides that show high biological activity, availability of innovative peptides in the market, and rise in incidence of chronic diseases worldwide. However, the intrinsic complexity for manufacturing and high cost of the active pharmaceutical ingredient (API) restricts the market growth. Nevertheless, ongoing R&D activities and increase in investment by the pharmaceutical companies offer ample opportunities to the market growth.
This global market is segmented on the basis of product type such as monoclonal antibodies (MABs), erythropoietin (EPO), and others. Based on application, the market is divided into oncology, blood disorder, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Sandoz International GmbH, Pfizer Inc. Roche Ltd, Teva Pharmaceuticals Industries Ltd, Celltrion Inc., Biocon Ltd., Dr.Reddys Laboratories Ltd, Medtronic plc, Cipla Inc, and Bachem Americas, Inc.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 GLOBAL GLYCOSYLATED PEPTIDE MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MONOCLONAL ANTIBODIES (MABS)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. ERYTHROPOIETIN (EPO)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. OTHERS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 GLOBAL GLYCOSYLATED PEPTIDE MARKET, BY APPLICATION TYPE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ONCOLOGY
5.2.1. Market size and forecast
5.3. BLOOD DISORDER
5.3.1. Market size and forecast
5.4. OTHERS
5.4.1. Market size and forecast
CHAPTER 6 GLOBAL GLYCOSYLATED PEPTIDE MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Glycosylated Peptide Market by Product Type
6.2.5. North America Glycosylated Peptide Market by Application
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Glycosylated Peptide Market by Product Type
6.3.5. Europe Glycosylated Peptide Market by Application
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Glycosylated Peptide Market by Product Type
6.4.5. Asia-Pacific Glycosylated Peptide Market by Application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Argentina market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Glycosylated Peptide Market by Product Type
6.4.5. Asia-Pacific Glycosylated Peptide Market by Application
CHAPTER 7 COMPANY PROFILES
7.1. SANDOZ INTERNATIONAL GMBH
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.3. PFIZER INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.3. ROCHE LTD
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. TEVA PHARMACEUTICALS INDUSTRIES LTD
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. CELLTRION INC
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. BIOCON LTD.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. DR.REDDY’S LABORATORIES LTD
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. MEDTRONIC PLC
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. BACHEM AMERICAS, INC.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. CIPLA INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
